Wells Fargo lowered the firm’s price target on Omega Healthcare to $32 from $33 and keeps an Equal Weight rating on the shares. The firm notes that Maplewood and LaVie have “hit a snag,” pushing out recovery expectations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OHI:
- Omega Healthcare downgraded to Underperform from Neutral at Exane BNP Paribas
- Omega Healthcare reports Q3 nareit FFO 63c, consensus 70c
- Omega Healthcare Investors (OHI) Q3 Earnings Cheat Sheet
- 2 Big Dividend Stocks Offering up to 8% Yield; Bank of America Says ‘Buy’
- Omega Healthcare initiated with a Neutral at Exane BNP Paribas
